Ganesa Wegienka1, Suzanne Havstad2, Edward M Zoratti3, Haejin Kim3, Dennis R Ownby4, Christine Cole Johnson2. 1. Department of Public Health Sciences, Henry Ford Hospital, Detroit, Mich. Electronic address: gwegien1@hfhs.org. 2. Department of Public Health Sciences, Henry Ford Hospital, Detroit, Mich. 3. Department of Internal Medicine, Division of Allergy, Henry Ford Hospital, Detroit, Mich. 4. Department of Pediatrics, Georgia Regents University, Augusta, Ga.
Abstract
BACKGROUND: Allergy-related studies that include biological measurements of vitamin D preceding well-measured outcomes are needed. OBJECTIVE: We sought to examine the associations between early-life vitamin D levels and the development of allergy-related outcomes in the racially diverse Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study birth cohort. METHODS: 25-Hydroxyvitamin D (25[OH]D) levels were measured in stored blood samples from pregnancy, cord blood, and age 2 years. Logistic regression models were used to calculate odds ratios (ORs) with 95% CIs for a 5 ng/mL increase in 25(OH)D levels for the following outcomes at age 2 years: eczema, skin prick tests (SPTs), increased allergen-specific IgE level (≥ 0.35 IU/mL), and doctor's diagnosis of asthma (3-6 years). RESULTS: Prenatal 25(OH)D levels were inversely associated with eczema (OR, 0.85; 95% CI, 0.75-0.96). The association was stronger in white children (white children: OR, 0.79; 95% CI, 0.57-1.09; black children: OR, 0.96; 95% CI, 0.82-1.12), although this was not statistically significant. Cord blood 25(OH)D levels were inversely associated with having 1 or more positive SPT responses and aeroallergen sensitization. Both associations were statistically significant in white children (positive SPT response: OR, 0.50; 95% CI, 0.32-0.80; ≥ 1 aeroallergen sensitization: OR, 0.50; 95% CI, 0.28-0.92) in contrast with black children (positive SPT response: OR, 0.88; 95% CI, 0.68-1.14; ≥ 1 aeroallergen sensitization: OR, 0.85; 95% CI, 0.65-1.11). 25(OH)D levels measured concurrently with outcome assessment were inversely associated with aeroallergen sensitization (OR, 0.79; 95% CI, 0.66-0.96) only among black children (white children: OR, 1.21; 95% CI, 0.87-1.69). CONCLUSIONS: Prenatal and cord blood 25(OH)D levels were associated with some allergy-related outcomes, with a general pattern indicating that children with higher 25(OH)D levels tend to have fewer allergy-related outcomes.
BACKGROUND:Allergy-related studies that include biological measurements of vitamin D preceding well-measured outcomes are needed. OBJECTIVE: We sought to examine the associations between early-life vitamin D levels and the development of allergy-related outcomes in the racially diverse Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study birth cohort. METHODS:25-Hydroxyvitamin D (25[OH]D) levels were measured in stored blood samples from pregnancy, cord blood, and age 2 years. Logistic regression models were used to calculate odds ratios (ORs) with 95% CIs for a 5 ng/mL increase in 25(OH)D levels for the following outcomes at age 2 years: eczema, skin prick tests (SPTs), increased allergen-specific IgE level (≥ 0.35 IU/mL), and doctor's diagnosis of asthma (3-6 years). RESULTS: Prenatal 25(OH)D levels were inversely associated with eczema (OR, 0.85; 95% CI, 0.75-0.96). The association was stronger in white children (white children: OR, 0.79; 95% CI, 0.57-1.09; black children: OR, 0.96; 95% CI, 0.82-1.12), although this was not statistically significant. Cord blood 25(OH)D levels were inversely associated with having 1 or more positive SPT responses and aeroallergen sensitization. Both associations were statistically significant in white children (positive SPT response: OR, 0.50; 95% CI, 0.32-0.80; ≥ 1 aeroallergen sensitization: OR, 0.50; 95% CI, 0.28-0.92) in contrast with black children (positive SPT response: OR, 0.88; 95% CI, 0.68-1.14; ≥ 1 aeroallergen sensitization: OR, 0.85; 95% CI, 0.65-1.11). 25(OH)D levels measured concurrently with outcome assessment were inversely associated with aeroallergen sensitization (OR, 0.79; 95% CI, 0.66-0.96) only among black children (white children: OR, 1.21; 95% CI, 0.87-1.69). CONCLUSIONS: Prenatal and cord blood 25(OH)D levels were associated with some allergy-related outcomes, with a general pattern indicating that children with higher 25(OH)D levels tend to have fewer allergy-related outcomes.
Authors: K Weisse; S Winkler; F Hirche; G Herberth; D Hinz; M Bauer; S Röder; U Rolle-Kampczyk; M von Bergen; S Olek; U Sack; T Richter; U Diez; M Borte; G I Stangl; I Lehmann Journal: Allergy Date: 2012-12-18 Impact factor: 13.146
Authors: G Wegienka; S Havstad; C L M Joseph; E Zoratti; D Ownby; K Woodcroft; C C Johnson Journal: Clin Exp Allergy Date: 2012-06 Impact factor: 5.018
Authors: Peter J Gergen; Stephen J Teach; Herman E Mitchell; Robert F Freishtat; Agustin Calatroni; Elizabeth Matsui; Meyer Kattan; Gordon R Bloomberg; Andrew H Liu; Carolyn Kercsmar; George O'Connor; Jacqueline Pongracic; Yadira Rivera-Sanchez; Wayne J Morgan; Christine A Sorkness; Neil Binkley; William Busse Journal: Am J Clin Nutr Date: 2013-04-17 Impact factor: 7.045
Authors: Katharine C Pike; Hazel M Inskip; Sian Robinson; Jane S Lucas; Cyrus Cooper; Nicholas C Harvey; Keith M Godfrey; Graham Roberts Journal: Thorax Date: 2012-06-15 Impact factor: 9.139
Authors: Hooman Mirzakhani; Vincent J Carey; Robert Zeiger; Leonard B Bacharier; George T O'Connor; Michael X Schatz; Nancy Laranjo; Scott T Weiss; Augusto A Litonjua Journal: Clin Exp Allergy Date: 2019-01-03 Impact factor: 5.018
Authors: Alexandra R Sitarik; Manish Arora; Christine Austin; Lawrence F Bielak; Shoshannah Eggers; Christine C Johnson; Susan V Lynch; Sung Kyun Park; Kuan-Han Hank Wu; Germaine J M Yong; Andrea E Cassidy-Bushrow Journal: Environ Int Date: 2020-08-29 Impact factor: 9.621
Authors: Sarah N Adams; Margaret A Adgent; Tebeb Gebretsadik; Terryl J Hartman; Shanda Vereen; Christina Ortiz; Frances A Tylavsky; Kecia N Carroll Journal: J Matern Fetal Neonatal Med Date: 2019-05-02